News

The Success of the ReproUnion facilitated Patient Mobility Agreement

Oct 29, 2018

The success in the ReproUnion facilitated Patient Mobility Agreement between Denmark and Sweden may lay the foundation for more bilateral health services between the two neighboring countries.

Last year, the Patient Mobility Agreement enabled childless couple with certain types of involuntary infertility to receive specialized treatment within a field of expertise that is not available in their home country in Malmö and Copenhagen area. Today, 40 Danish and Swedish patients have already made use of the patient mobility agreement.

– The agreement is, beyond being of benefit for the individual patient undergoing fertility treatment, a good example of how patients in both countries can benefit from the cross-border resources available.

States Dr. Jens Sønksen, Professor of Urology at University of Copenhagen and Head of Urological Research Center, Herlev Hospital, Denmark and Chairman of ReproUnion Board.

– In my opinion, the project model of the patient mobility agreement is worth looking further to investigate how we better can use our resources to get the best possible treatment for our patient. In the end, that’s what it’s all about.

Chairman of the Regional Council of Copenhagen, Sophie Hæstorp Andersen also believes that there are great benefits of cooperation with Sweden for both Danish and Swedish patients. Read more here

MORE NEWS


Welcome back Mette Bach Dyremose

We’re thrilled to welcome back Mette Bach Dyremose to the ReproUnion Management Team as she takes on a part-time role to lead ReproUnion's communication efforts! With over 20 years of experience in strategic communication, business development, and life sciences,...

read more

RUBIC Seminar – The Team Makes the Dream Work

On October 3. we gathered more than 60 people for the 2024 RUBIC Seminar, a networking event for the dedicated people involved in patient recruitment, clinical visits, sample preparation, and data analysis as well as other colleagues in contact with RUBIC in their...

read more

Defective sperm doubles the risk of preeclampsia

We’re excited to share new findings from Lund University, led by ReproUnion researcher Aleksander Giwercman. For the first time, researchers have linked specific sperm defects to pregnancy complications and adverse effects on the child’s health. The study shows that...

read more

Tour de Health

Great to have ReproUnion on the agenda on this years Tour de Health conference hosted by Ferring Pharmaceuticals arranged by Healthcare Denmark. Lars Løkke Rasmussen attended the conference and his presence highlights the growing political attention on reproductive...

read more